Author: Alzheimer’s Drug Discovery Foundation

Posted Date:

March 17, 2026

ADDF Launches New Phase of $150 Million Diagnostics Accelerator Initiative to Power Next Generation of Alzheimer’s Precision Medicine Worldwide

Alzheimer’s Drug Discovery Foundation

March 17, 2026
Alzheimer’s Drug Discovery Foundation Appoints Isobel Coleman as Chief Executive Officer to Lead Next Era of Alzheimer’s Breakthroughs

Alzheimer’s Drug Discovery Foundation

March 11, 2026
ADDF Awards Prestigious 2026 Melvin R. Goodes Prize to Alzheimer’s Research Pioneer Randall J. Bateman, MD

Alzheimer’s Drug Discovery Foundation

February 18, 2026